Philip Marmon

Philip Marmon is an Associate Director in Clinical Trial Management with a PhD in Translational Toxicology and Drug Safety from Brunel University London. Previously, Philip held various positions at Oxford Immunotec as a QC/QA Scientist and as a Junior Quality Scientist. From 2022 to 2023, Philip worked at Medpace, progressing from Clinical Trial Manager to Associate Director. Philip also completed an undergraduate research project at The University of Sheffield during the summer of 2014.